1
|
Schuler SMM, Jürjens G, Marker A, Hemmann U, Rey A, Yvon S, Lagrevol M, Hamiti M, Nguyen F, Hirsch R, Pöverlein C, Vilcinskas A, Hammann P, Wilson DN, Mourez M, Coyne S, Bauer A. Full Profiling of GE81112A, an Underexplored Tetrapeptide Antibiotic with Activity against Gram-Negative Pathogens. Microbiol Spectr 2023; 11:e0224722. [PMID: 37140391 PMCID: PMC10269895 DOI: 10.1128/spectrum.02247-22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2023] [Accepted: 01/19/2023] [Indexed: 05/05/2023] Open
Abstract
After the first total synthesis combined with structure revision, we performed thorough in vitro and in vivo profiling of the underexplored tetrapeptide GE81112A. From the determination of the biological activity spectrum and physicochemical and early absorption-distribution-metabolism-excretion-toxicity (eADMET) properties, as well as in vivo data regarding tolerability and pharmacokinetics (PK) in mice and efficacy in an Escherichia coli-induced septicemia model, we were able to identify the critical and limiting parameters of the original hit compound. Thus, the generated data will serve as the basis for further compound optimization programs and developability assessments to identify candidates for preclinical/clinical development derived from GE81112A as the lead structure. IMPORTANCE The spread of antimicrobial resistance (AMR) is becoming a more and more important global threat to human health. With regard to current medical needs, penetration into the site of infection represents the major challenge in the treatment of infections caused by Gram-positive bacteria. Considering infections associated with Gram-negative bacteria, resistance is a major issue. Obviously, novel scaffolds for the design of new antibacterials in this arena are urgently needed to overcome this crisis. Such a novel potential lead structure is represented by the GE81112 compounds, which inhibit protein synthesis by interacting with the small 30S ribosomal subunit using a binding site distinct from that of other known ribosome-targeting antibiotics. Therefore, the tetrapeptide antibiotic GE81112A was chosen for further exploration as a potential lead for the development of antibiotics with a new mode of action against Gram-negative bacteria.
Collapse
Affiliation(s)
- Sören M. M. Schuler
- Branch Bioresources of the Fraunhofer Institute for Molecular Biology and Applied Ecology, Giessen, Germany
| | - Gerrit Jürjens
- Branch Bioresources of the Fraunhofer Institute for Molecular Biology and Applied Ecology, Giessen, Germany
| | | | | | - Astrid Rey
- Sanofi R&D, Therapeutic Area Infectious Diseases, Marcy L’Etoile, France
| | - Stéphane Yvon
- Sanofi R&D, Therapeutic Area Infectious Diseases, Marcy L’Etoile, France
| | - Marjorie Lagrevol
- Sanofi R&D, Therapeutic Area Infectious Diseases, Marcy L’Etoile, France
| | - Mohamed Hamiti
- Sanofi R&D, Therapeutic Area Infectious Diseases, Marcy L’Etoile, France
| | - Fabian Nguyen
- Gene Center, Department for Biochemistry and Center for Protein Science Munich, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Rolf Hirsch
- Branch Bioresources of the Fraunhofer Institute for Molecular Biology and Applied Ecology, Giessen, Germany
| | | | - Andreas Vilcinskas
- Branch Bioresources of the Fraunhofer Institute for Molecular Biology and Applied Ecology, Giessen, Germany
- Institute for Insect Biotechnology, Justus-Liebig University of Giessen, Giessen, Germany
| | | | - Daniel N. Wilson
- Gene Center, Department for Biochemistry and Center for Protein Science Munich, Ludwig-Maximilians-Universität München, Munich, Germany
| | - Michael Mourez
- Sanofi R&D, Therapeutic Area Infectious Diseases, Marcy L’Etoile, France
| | - Sebastien Coyne
- Sanofi R&D, Therapeutic Area Infectious Diseases, Marcy L’Etoile, France
| | - Armin Bauer
- Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany
| |
Collapse
|
2
|
Fayad S, Jafari A, Schuler SMM, Kurz M, Plettenburg O, Hammann PE, Bauer A, Jürjens G, Pöverlein C. Total Synthesis of GE81112A: An Orthoester-Based Approach. J Org Chem 2023; 88:5597-5608. [PMID: 37023463 PMCID: PMC10167690 DOI: 10.1021/acs.joc.3c00094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/08/2023]
Abstract
The GE81112 series, consisting of three naturally occurring tetrapeptides and synthetic derivatives, is evaluated as a potential lead structure for the development of a new antibacterial drug. Although the first total synthesis of GE81112A reported by our group provided sufficient amounts of material for an initial in depth biological profiling of the compound, improvements of the routes toward the key building blocks were needed for further upscaling and structure-activity relationship studies. The major challenges identified were poor stereoselectivity in the synthesis of the C-terminal β-hydroxy histidine intermediate and a concise access to all four isomers of the 3-hydroxy pipecolic acid. Herein, we report a second-generation synthesis of GE81112A, which is also applicable to access further representatives of this series. Based on Lajoie's ortho-ester-protected serine aldehydes as key building blocks, the described route provides both a satisfactory improvement in stereoselectivity of the β-hydroxy histidine intermediate synthesis and a stereoselective approach toward both orthogonally protected cis and trans-3-hydroxy pipecolic acid.
Collapse
Affiliation(s)
- Scherin Fayad
- Sanofi-Aventis Deutschland GmbH, R&D, Integrated Drug Discovery, Industriepark Hoechst, 65926 Frankfurt am Main, Germany
- Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Institut für Medizinalchemie, 30167 Hannover, Germany
| | - Ardalan Jafari
- Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Institut für Medizinalchemie, 30167 Hannover, Germany
| | - Sören M M Schuler
- Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Branch for Bioresources, 35392 Giessen, Germany
- Evotec International GmbH, 37079 Göttingen, Germany
| | - Michael Kurz
- Sanofi-Aventis Deutschland GmbH, R&D, Integrated Drug Discovery, Industriepark Hoechst, 65926 Frankfurt am Main, Germany
| | - Oliver Plettenburg
- Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Institut für Medizinalchemie, 30167 Hannover, Germany
| | - Peter E Hammann
- Evotec International GmbH, 37079 Göttingen, Germany
- Sanofi-Aventis Deutschland GmbH, R&D, Infectious Diseases, Industriepark Hoechst, 65926 Frankfurt am Main, Germany
| | - Armin Bauer
- Sanofi-Aventis Deutschland GmbH, R&D, Integrated Drug Discovery, Industriepark Hoechst, 65926 Frankfurt am Main, Germany
| | - Gerrit Jürjens
- Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Institut für Medizinalchemie, 30167 Hannover, Germany
- Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Branch for Bioresources, 35392 Giessen, Germany
| | - Christoph Pöverlein
- Sanofi-Aventis Deutschland GmbH, R&D, Integrated Drug Discovery, Industriepark Hoechst, 65926 Frankfurt am Main, Germany
| |
Collapse
|
3
|
Aldholmi M, Ahmad R, Carretero‐Molina D, Pérez‐Victoria I, Martín J, Reyes F, Genilloud O, Gourbeyre L, Gefflaut T, Carlsson H, Maklakov A, O'Neill E, Field RA, Wilkinson B, O'Connell M, Ganesan A. Euglenatides, Potent Antiproliferative Cyclic Peptides Isolated from the Freshwater Photosynthetic Microalga Euglena gracilis. Angew Chem Int Ed Engl 2022; 61:e202203175. [PMID: 35325497 PMCID: PMC9321709 DOI: 10.1002/anie.202203175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2022] [Indexed: 11/27/2022]
Abstract
By limiting the nitrogen source to glutamic acid, we isolated cyclic peptides from Euglena gracilis containing asparagine and non-proteinogenic amino acids. Structure elucidation was accomplished through spectroscopic methods, mass spectrometry and chemical degradation. The euglenatides potently inhibit pathogenic fungi and cancer cell lines e.g., euglenatide B exhibiting IC50 values of 4.3 μM in Aspergillus fumigatus and 0.29 μM in MCF-7 breast cancer cells. In an unprecedented convergence of non-ribosomal peptide synthetase and polyketide synthase assembly-line biosynthesis between unicellular species and the metazoan kingdom, euglenatides bear resemblance to nemamides from Caenorhabditis elegans and inhibited both producing organisms E. gracilis and C. elegans. By molecular network analysis, we detected over forty euglenatide-like metabolites in E. gracilis, E. sanguinea and E. mutabilis, suggesting an important biological role for these natural products.
Collapse
Affiliation(s)
- Mohammed Aldholmi
- Natural Products and Alternative MedicineCollege of Clinical PharmacyImam Abdulrahman Bin Faisal UniversityDammam31441Saudi Arabia
| | - Rizwan Ahmad
- Natural Products and Alternative MedicineCollege of Clinical PharmacyImam Abdulrahman Bin Faisal UniversityDammam31441Saudi Arabia
| | - Daniel Carretero‐Molina
- Fundación MEDINACentro de Excelencia en Investigación de Medicamentos Innovadores en AndalucíaAvenida del Conocimiento 3418016ArmillaGranadaSpain
| | - Ignacio Pérez‐Victoria
- Fundación MEDINACentro de Excelencia en Investigación de Medicamentos Innovadores en AndalucíaAvenida del Conocimiento 3418016ArmillaGranadaSpain
| | - Jesús Martín
- Fundación MEDINACentro de Excelencia en Investigación de Medicamentos Innovadores en AndalucíaAvenida del Conocimiento 3418016ArmillaGranadaSpain
| | - Fernando Reyes
- Fundación MEDINACentro de Excelencia en Investigación de Medicamentos Innovadores en AndalucíaAvenida del Conocimiento 3418016ArmillaGranadaSpain
| | - Olga Genilloud
- Fundación MEDINACentro de Excelencia en Investigación de Medicamentos Innovadores en AndalucíaAvenida del Conocimiento 3418016ArmillaGranadaSpain
| | - Léa Gourbeyre
- Université Clermont AuvergneClermont Auvergne INP, CNRS, Institut Pascal63000Clermont-FerrandFrance
| | - Thierry Gefflaut
- Université Clermont AuvergneClermont Auvergne INP, CNRS, Institut Pascal63000Clermont-FerrandFrance
| | - Hanne Carlsson
- School of Biological SciencesUniversity of East AngliaNorwich Research ParkNorwichNR4 7TJUK
| | - Alexei Maklakov
- School of Biological SciencesUniversity of East AngliaNorwich Research ParkNorwichNR4 7TJUK
| | - Ellis O'Neill
- School of ChemistryUniversity of NottinghamNottinghamNG7 2RDUK
| | - Robert A. Field
- Manchester Institute of BiotechnologyUniversity of ManchesterManchesterM1 7DNUK
| | | | - Maria O'Connell
- School of PharmacyUniversity of East AngliaNorwich Research ParkNorwichNR4 7TJUK
| | - A. Ganesan
- School of PharmacyUniversity of East AngliaNorwich Research ParkNorwichNR4 7TJUK
| |
Collapse
|
4
|
Aldholmi M, Ahmad R, Carretero‐Molina D, Pérez‐Victoria I, Martín J, Reyes F, Genilloud O, Gourbeyre L, Gefflaut T, Carlsson H, Maklakov A, O'Neill E, Field RA, Wilkinson B, O'Connell M, Ganesan A. Euglenatides, Potent Antiproliferative Cyclic Peptides Isolated from the Freshwater Photosynthetic Microalga
Euglena gracilis. Angew Chem Int Ed Engl 2022. [DOI: 10.1002/ange.202203175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Mohammed Aldholmi
- Natural Products and Alternative Medicine College of Clinical Pharmacy Imam Abdulrahman Bin Faisal University Dammam 31441 Saudi Arabia
| | - Rizwan Ahmad
- Natural Products and Alternative Medicine College of Clinical Pharmacy Imam Abdulrahman Bin Faisal University Dammam 31441 Saudi Arabia
| | - Daniel Carretero‐Molina
- Fundación MEDINA Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía Avenida del Conocimiento 34 18016 Armilla Granada Spain
| | - Ignacio Pérez‐Victoria
- Fundación MEDINA Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía Avenida del Conocimiento 34 18016 Armilla Granada Spain
| | - Jesús Martín
- Fundación MEDINA Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía Avenida del Conocimiento 34 18016 Armilla Granada Spain
| | - Fernando Reyes
- Fundación MEDINA Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía Avenida del Conocimiento 34 18016 Armilla Granada Spain
| | - Olga Genilloud
- Fundación MEDINA Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía Avenida del Conocimiento 34 18016 Armilla Granada Spain
| | - Léa Gourbeyre
- Université Clermont Auvergne Clermont Auvergne INP, CNRS, Institut Pascal 63000 Clermont-Ferrand France
| | - Thierry Gefflaut
- Université Clermont Auvergne Clermont Auvergne INP, CNRS, Institut Pascal 63000 Clermont-Ferrand France
| | - Hanne Carlsson
- School of Biological Sciences University of East Anglia Norwich Research Park Norwich NR4 7TJ UK
| | - Alexei Maklakov
- School of Biological Sciences University of East Anglia Norwich Research Park Norwich NR4 7TJ UK
| | - Ellis O'Neill
- School of Chemistry University of Nottingham Nottingham NG7 2RD UK
| | - Robert A. Field
- Manchester Institute of Biotechnology University of Manchester Manchester M1 7DN UK
| | | | - Maria O'Connell
- School of Pharmacy University of East Anglia Norwich Research Park Norwich NR4 7TJ UK
| | - A. Ganesan
- School of Pharmacy University of East Anglia Norwich Research Park Norwich NR4 7TJ UK
| |
Collapse
|
5
|
Chiral secondary amino acids, their importance, and methods of analysis. Amino Acids 2022; 54:687-719. [PMID: 35192062 DOI: 10.1007/s00726-022-03136-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2021] [Accepted: 02/04/2022] [Indexed: 11/01/2022]
Abstract
Naturally occurring secondary amino acids, with proline as the main representative, contain an alpha-imino group in a cycle that is typically four-, five-, and six-membered. The unique ring structure exhibits exceptional properties-conformational rigidity, chemical stability, and specific roles in protein structure and folding. Many proline analogues have been used as valuable compounds for the study of metabolism of both prokaryotic and eukaryotic cells and for the synthesis of compounds with desired biological, pharmaceutical, or industrial properties. The D-forms of secondary amino acids play different roles in living organisms than the L-forms. They have different metabolic pathways, biological, physiological, and pharmacological effects, they can be indicators of changes and also serve as biomarkers of diseases. In the scientific literature, the number of articles examining D-amino acids in biological samples is increasing. The review summarises information on the occurrence and importance of D- and L-secondary amino acids-azetidic acid, proline, hydroxyprolines, pipecolic, nipecotic, hydroxypipecolic acids and related peptides containing these D-AAs, as well as the main analytical methods (mostly chromatographic) used for their enantiomeric determination in different matrices (biological samples, plants, food, water, and soil).
Collapse
|
6
|
Stout CN, Renata H. Reinvigorating the Chiral Pool: Chemoenzymatic Approaches to Complex Peptides and Terpenoids. Acc Chem Res 2021; 54:1143-1156. [PMID: 33543931 DOI: 10.1021/acs.accounts.0c00823] [Citation(s) in RCA: 32] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Biocatalytic transformations that leverage the selectivity and efficiency of enzymes represent powerful tools for the construction of complex natural products. Enabled by innovations in genome mining, bioinformatics, and enzyme engineering, synthetic chemists are now more than ever able to develop and employ enzymes to solve outstanding chemical problems, one of which is the reliable and facile generation of stereochemistry within natural product scaffolds. In recognition of this unmet need, our group has sought to advance novel chemoenzymatic strategies to both expand and reinvigorate the chiral pool. Broadly defined, the chiral pool comprises cheap, enantiopure feedstock chemicals that serve as popular foundations for asymmetric total synthesis. Among these building blocks, amino acids and enantiopure terpenes, whose core structures can be mapped onto several classes of structurally and pharmaceutically intriguing natural products, are of particular interest to the synthetic community.In this Account, we summarize recent efforts from our group in leveraging biocatalytic transformations to expand the chiral pool, as well as efforts toward the efficient application of these transformations in natural products total synthesis, the ultimate testing ground for any novel methodology. First, we describe several examples of enzymatic generation of noncanonical amino acids as means to simplify the synthesis of peptide natural products. By extracting amino acid hydroxylases from native biosynthetic pathways, we obtain efficient access to hydroxylated variants of proline, lysine, arginine, and their derivatives. The newly installed hydroxyl moiety then becomes a chemical handle that can facilitate additional complexity generation, thereby expanding the pool of amino acid-derived building blocks available for peptide synthesis. Next, we present our efforts in enzymatic C-H oxidations of diverse terpene scaffolds, in which traditional chemistry can be combined with strategic applications of biocatalysis to selectively and efficiently derivatize several commercial terpenoid skeletons. The synergistic logic of this approach enables a small handful of synthetic intermediates to provide access to a plethora of terpenoid natural product families. Taken together, these findings demonstrate the advantages of applying enzymes in total synthesis in conjunction with established methodologies, as well as toward the expansion of the chiral pool to enable facile incorporation of stereochemistry during synthetic campaigns.
Collapse
Affiliation(s)
- Carter N. Stout
- Department of Chemistry, Scripps Research, 110 Scripps Way, Jupiter, Florida 33458, United States
| | - Hans Renata
- Department of Chemistry, Scripps Research, 110 Scripps Way, Jupiter, Florida 33458, United States
| |
Collapse
|
7
|
Zwick CR, Sosa MB, Renata H. Modular Chemoenzymatic Synthesis of GE81112 B1 and Related Analogues Enables Elucidation of Its Key Pharmacophores. J Am Chem Soc 2021; 143:1673-1679. [PMID: 33416325 DOI: 10.1021/jacs.0c13424] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
The GE81112 complex has garnered much interest due to its broad antimicrobial properties and unique ability to inhibit bacterial translation initiation. Herein we report the use of a chemoenzymatic strategy to complete the first total synthesis of GE81112 B1. By pairing iron and α-ketoglutarate dependent hydroxylases found in GE81112 biosynthesis with traditional synthetic methodology, we were able to access the natural product in 11 steps (longest linear sequence). Following this strategy, 10 GE81112 B1 analogues were synthesized, allowing for identification of its key pharmacophores. A key feature of our medicinal chemistry effort is the incorporation of additional biocatalytic hydroxylations in modular analogue synthesis to rapidly enable exploration of relevant chemical space.
Collapse
Affiliation(s)
- Christian R Zwick
- Department of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, Florida 33458, United States
| | - Max B Sosa
- Department of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, Florida 33458, United States
| | - Hans Renata
- Department of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, Florida 33458, United States
| |
Collapse
|
8
|
Qi WY, Fang SL, Xu XT, Zhang K, Shi BF. Asymmetric formal synthesis of (−)-tetrazomine. Org Chem Front 2021. [DOI: 10.1039/d1qo00029b] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The asymmetric formal synthesis of (−)-tetrazomine, a structurally unique member of the tetrahydroisoquinoline alkaloids, is presented.
Collapse
Affiliation(s)
- Wei-Yi Qi
- School of Biotechnology and Health Sciences
- Wuyi University
- Jiangmen
- China
- International Healthcare Innovation Institute(Jiangmen)
| | - Sheng-Long Fang
- Department of Chemistry
- Zhejiang University
- Hangzhou
- 310027 China
| | - Xue-Tao Xu
- School of Biotechnology and Health Sciences
- Wuyi University
- Jiangmen
- China
- International Healthcare Innovation Institute(Jiangmen)
| | - Kun Zhang
- School of Biotechnology and Health Sciences
- Wuyi University
- Jiangmen
- China
- International Healthcare Innovation Institute(Jiangmen)
| | - Bing-Feng Shi
- Department of Chemistry
- Zhejiang University
- Hangzhou
- 310027 China
| |
Collapse
|
9
|
Farhid H, Nazeri MT, Shaabani A, Armaghan M, Janiak C. Isocyanide-based consecutive Bargellini/Ugi reactions: an efficient method for the synthesis of pseudo-peptides containing three amide bonds. Amino Acids 2020; 53:1-10. [PMID: 33247358 DOI: 10.1007/s00726-020-02917-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2019] [Accepted: 11/13/2020] [Indexed: 01/25/2023]
Abstract
Isocyanide-based consecutive Bargellini/Ugi multicomponent reactions as a combinatorial strategy have been developed for the synthesis of new class of pseudo-peptides. Via Bargellini reaction 3-carboxamido-isobutyric acids are prepared using acetone, chloroform, sodium hydroxide, and isocyanides. Then, using Ugi multicomponent reaction strategy, pseudo-peptides containing three amide bonds are synthesized using the Bargellini reaction product, aldehydes, amines, and isocyanides. This is an efficient and eco-friendly approach for easy access to wide variety of structurally diverse, drug-like pseudo-peptides from cheap and readily available precursors in high yields.
Collapse
Affiliation(s)
- Hassan Farhid
- Faculty of Chemistry, Shahid Beheshti University, G.C., P.O. Box 19396-4716, Tehran, Iran
| | - Mohammad Taghi Nazeri
- Faculty of Chemistry, Shahid Beheshti University, G.C., P.O. Box 19396-4716, Tehran, Iran
| | - Ahmad Shaabani
- Faculty of Chemistry, Shahid Beheshti University, G.C., P.O. Box 19396-4716, Tehran, Iran.
| | - Mahsa Armaghan
- Institut Für Anorganische Chemie und Strukturchemie, Heinrich-Heine-Universität Düsseldorf, 40204, Düsseldorf, Germany
| | - Christoph Janiak
- Institut Für Anorganische Chemie und Strukturchemie, Heinrich-Heine-Universität Düsseldorf, 40204, Düsseldorf, Germany
| |
Collapse
|